These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [32-year-old patient with acute myocardial infarction possibly induced by the appetite suppressant sibutramine]. Pöss J; Böhm M; Link A Dtsch Med Wochenschr; 2010 May; 135(19):965-8. PubMed ID: 20446231 [TBL] [Abstract][Full Text] [Related]
5. Myocardial infarction induced by appetite suppressants in Malaysia. Azarisman SM; Magdi YA; Noorfaizan S; Oteh M N Engl J Med; 2007 Nov; 357(18):1873-4. PubMed ID: 17978302 [No Abstract] [Full Text] [Related]
6. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. James WP; Caterson ID; Coutinho W; Finer N; Van Gaal LF; Maggioni AP; Torp-Pedersen C; Sharma AM; Shepherd GM; Rode RA; Renz CL; N Engl J Med; 2010 Sep; 363(10):905-17. PubMed ID: 20818901 [TBL] [Abstract][Full Text] [Related]
7. Severe symptomatic hyponatremia during sibutramine therapy: a case report. Esposito P; Rampino T; Gregorini M; Soccio G; Piotti G; Bedino G; Balenzano CT; Roscini E; Cosmai L; Portalupi V; Libetta C; Dal Canton A Am J Kidney Dis; 2008 Jul; 52(1):137-9. PubMed ID: 18487000 [TBL] [Abstract][Full Text] [Related]
8. Acute myocardial infarction in a 24 year-old man possibly associated with sibutramine use. Eroglu E; Gemici G; Bayrak F; Kalkan AK; Degertekin M Int J Cardiol; 2009 Oct; 137(2):e43-5. PubMed ID: 18687492 [TBL] [Abstract][Full Text] [Related]
9. The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom. Hayes JF; Bhaskaran K; Batterham R; Smeeth L; Douglas I Int J Obes (Lond); 2015 Sep; 39(9):1359-64. PubMed ID: 25971925 [TBL] [Abstract][Full Text] [Related]
10. A case of sibutramine-induced hyperprolactinemia. Soares Leaes CG; Pereira-Lima JF; da Costa Oliveira M Neuro Endocrinol Lett; 2011; 32(5):616-8. PubMed ID: 22167128 [TBL] [Abstract][Full Text] [Related]
11. Sibutramine-associated QT interval prolongation and cardiac arrest. Ernest D; Gershenzon A; Corallo CE; Nagappan R Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104 [TBL] [Abstract][Full Text] [Related]
12. Sibutramine may be associated with memory impairment. Clark DW; Harrison-Woolrych M BMJ; 2004 Dec; 329(7478):1316. PubMed ID: 15576742 [No Abstract] [Full Text] [Related]
14. Effect of Sibutramine on Upper Eyelid Position. Feijó ED; Matayoshi S Ophthalmic Plast Reconstr Surg; 2018; 34(4):397-398. PubMed ID: 29985883 [No Abstract] [Full Text] [Related]
15. [About the withdrawal of sibutramine in Peru]. Dongo V Rev Peru Med Exp Salud Publica; 2010; 27(4):649-50. PubMed ID: 21308210 [No Abstract] [Full Text] [Related]
16. Sibutramine (Meridia) withdrawn. Med Lett Drugs Ther; 2010 Nov; 52(1350):88. PubMed ID: 21045763 [No Abstract] [Full Text] [Related]
17. Severe bullous drug eruption due to sibutramine (Reductil). Goh BK; Ng PP; Giam YC Br J Dermatol; 2003 Jul; 149(1):215-6. PubMed ID: 12890232 [No Abstract] [Full Text] [Related]
18. Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand. Harrison-Woolrych M; Hill GR; Clark DW Int J Obes (Lond); 2006 Aug; 30(8):1315-7. PubMed ID: 16491106 [TBL] [Abstract][Full Text] [Related]